参考文献

1.Bentzen SM，Parliament M，Deasy JO，et al.Biomarkers and surrogate endpoints for normal-tissue effects of radiation therapy：the importance of dose-volume effects.Int J Radiat Oncol Biol Phys，2010，76 ：145-150.

2.Meirovitz A，Kuten M，Billan S，et al.Cytokines levels，Severity of acute mucositis and the need of PEG tube installation during chemo-radiation for head and neck cancer-a prospective pilot study.Radiat Oncol，2010，5 ：1-7.

3.Onal C，Kotek A，Unal B，et al.Plasma citrulline levels predict intestinal toxicity in patients treated with pelvic radiotherapy.Acta Oncol，2011，50 ：1167-1174.

4.Citrin DE，Ying JH，Chung EJ，et al.Determination of cytokine protein levels in oral secretions in patients undergoing radiotherapy for head and neck malignancies.Radiat Oncol，2012，26，7 ：64.

5.Niu X，Li H，Chen Z，et al.A study of ethnic differences in TGFβ1 gene polymorphisms and effects on the risk of radiation pneumonitis in non-small-cell lung cancer.J Thorac Oncol，2012，7 ：1668-1675.

6.Wang YS，Chang HJ，Chang YC，et al.Serum amyloid a as a predictive marker for radiation pneumonitis in lung cancer patients.Int J Radiat Oncol Biol Phys，2013，85 ：791-7.

7.Forrester HB，Ivashkevich A，Mckay MJ，et al.Follistatin is induced by ionizing radiation and potentially predictive of radiosensitivity in radiation-induced fibrosis patient derived fibroblasts.Plos One，2013，8 ：e77119.

8.Widłak P，Pietrowska M，Polańska J，et al.Radiotherapy-related changes in serum proteome patterns of head and neck cancer patients；the effect of low and medium doses of radiation delivered to large volumes of normal tissue.J Transl Med，2013 5，11 ：299.

9.Liu Y，Xia T，Zhang W，et al.Variations of circulating endothelial progenitor cells and transforming growth factor-beta-1（TGF-β1）during thoracic radiotherapy are predictive for radiation pneumonitis.Radiat Oncol，2013，8 ：189.

10.Jelonek K，Pietrowska M，Ros M，et al.Radiation-induced changes in serum lipidome of head and neck cancer patients.Int J Mol Sci，2014，15 ：6609-6624.

11.Tang C，Gomez DR，Wang H，et al.Association between white blood cell count following radiation therapy with radiation pneumonitis in non-small cell lung cancer.Int J Radiat Oncol Biol Phys，2014，88 ：319-325.

12.Xu T，Liao Z，O’Reilly MS，et al.Serum inflammatory miRNAs predict radiation esophagitis in patients receiving definitive radiochemotherapy for non-small cell lung cancer.Radiother Oncol，2014，113 ：379-384.

13.Sprung CN，Forrester HB，Siva S，et al.Immunological markers that predict radiation toxicity.Cancer Lett，2015，368 ：191-197.

14.Chethana，Rao PS，Madathil LP，et al.Quantitative analysis of acute phase proteins in post chemo-radiation mucositis.J Clin Diagn Res，2015，9 ：28-31.

15.Pietrowska M，Jelonek K，Polanska J，et al.Partial-body irradiation in patients with prostate cancer treated with IMRT has little effect on the composition of serum proteome.Proteomes，2015，3 ：117-131.

16.Villa A，Sonis S.Toxicities associated with head and neck cancer treatment and oncology-related clinical trials.Curr Probl Cancer，2016，40 ：244.

17.Shen ZT，Shen JS，Ji XQ，et al.TGF-β1 rs1982073 polymorphism contributes to radiation pneumonitis in lung cancer patients：a meta-analysis.J Cell Mol Med，2016，20 ：2405-2409.

18.Bujold K，Hauerjensen M，Donini O，et al.Citrulline as a biomarker for gastrointestinal-acute radiation syndrome：species differences and experimental condition effects.Radiat Res，2016，186 ：71-78.

19.Jelonek K，Pietrowska M，Widlak P.Systemic effects of ionizing radiation at the proteome and metabolome levels in the blood of cancer patients treated with radiotherapy：The influence of inflammation and radiation toxicity.Int J Radiat Biol，2017，93 ：683-696.

20.Normando AGC，Rocha CL，Toledo IPD，et al.Biomarkers in the assessment of oral mucositis in head and neck cancer patients：a systematic review and meta-analysis.Supportive Care Cancer，2017，28 ：1-20.

21.Normando AGC，Rocha CL，Toledo IPD，et al.Biomarkers in the assessment of oral mucositis in head and neck cancer patients：a systematic review and meta-analysis.Support Care Cancer，2017，25 ：2969-2688.

22.Lee YH，Choi HS，Jeong H，et al.Neutrophil-lymphocyte ratio and a dosimetric factor for predicting symptomatic radiation pneumonitis in non-small-cell lung cancer patients treated with concurrent chemoradiotherapy.Clin Respir J，2017，12 ：1264-1273.

23.Jelonek K，Pietrowska M，Widlak P.Systemic effects of ionizing radiation at the proteome and metabolome levels in the blood of cancer patients treated with radiotherapy：The influence of inflammation and radiation toxicity.Int J Radiat Biol，2017，93 ：683-696.